Stock Movers Eli Lilly Gains, McCormick Rises, Allbirds Soars on American Exchange Deal
Mar 31, 2026
Valdana Hyrik, a market analyst who summarizes fast-moving equity news. She breaks down Eli Lilly’s big buy to broaden its pipeline. She outlines the McCormick-Unilever food combination and its market implications. She covers Allbirds’ asset sale and the brand’s rise and decline.
AI Snips
Chapters
Transcript
Episode notes
Eli Lilly Expands Into Sleep Medicine
- Eli Lilly is expanding beyond weight-loss drugs into sleep medicine with a deal for Centessa Pharmaceuticals worth up to $7.8 billion.
- Valdana Hyrik said Lilly will pay $38 a share plus $9 on milestones, signaling a push to broaden its treatment pipeline.
McCormick and Unilever Create Global Seasonings Company
- Unilever agreed to combine its food business with McCormick in a roughly $45 billion transaction to create a global seasonings and sauces company.
- Valdana Hyrik noted big food firms have struggled as less wealthy consumers trade down to cheaper store brands, pressuring sales.
McCormick Shares Drop After Deal Announcement
- The McCormick stock reaction was volatile, falling as much as 10% intraday and about 6% at one point after the deal news.
- Hyrik tied the drop to broader consumer spending shifts and brand pressure from cheaper private-label competition.